Modeling Survival Outcomes of Immune Checkpoint Inhibitors on Locally Advanced Non-Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

被引：0
|
作者：
Huang, H. T. [1 ]
Hawkins, M. A. [1 ,2 ]
Fenwick, J. D. [3 ,4 ]
Nix, M. G. [5 ]
机构：
[1] UCL, Dept Med Phys & Biomed Engn, London, England
[2] CRUK RadNet City London, London, England
[3] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England
[4] Clatterbridge Canc Ctr, Dept Phys, Wirral, Merseyside, England
[5] Leeds Teaching Hosp NHS Trust, Dept Med Phys & Engn, Leeds, W Yorkshire, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2840
引用
收藏
页码：E375 / E375
页数：1
相关论文
共 50 条
  • [31] Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
    Liu, FangJie
    Wu, YingJia
    Shao, JianHui
    Qiu, Bo
    Guo, SuPing
    Luo, QiaoTing
    Guo, JinYu
    Wang, DaQuan
    Chu, Chu
    Zhou, Rui
    Chen, NaiBin
    Ai, XinLei
    Liu, Hui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Efficacy of Immune Checkpoint Inhibitors for Locally Advanced Non-Small Cell Lung Cancer Patients Before Durvalumab Approval
    Fukui, T.
    Hosotani, S.
    Soda, I.
    Ishiyama, H.
    Ishihara, M.
    Kasajima, M.
    Hiyoshi, Y.
    Igawa, S.
    Katagiri, S.
    Naoki, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S743 - S744
  • [33] Daily Step Counts Predict Outcomes for Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
    Ohri, N.
    Halmos, B.
    Bodner, W. R., III
    Cheng, H.
    Guha, C.
    Kalnicki, S.
    Garg, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E524 - E525
  • [34] Concurrent chemoradiotherapy in non-small cell lung cancer
    O'Rourke, Noelle
    Roque i Figuls, Marta
    Farre Bernado, Nuria
    Macbeth, Fergus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [35] Respiratory toxicities after concurrent chemoradiotherapy and subsequent consolidation immune checkpoint inhibitors in locally advanced non-small cell lung cancer: Infectious and non-infectious subtypes by pathogen NGS testing
    Qiu, Bo
    Xiong, Mai
    Liu, FangJie
    Zhang, PengXin
    Zhou, Rui
    Wang, DaQuan
    Luo, YiFeng
    Liu, Yimei
    Guo, Jinyu
    Chen, NaiBin
    Li, Shiyue
    Liu, Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Survival outcomes of patients with non-small cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, So-Hee
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 347 - 347
  • [37] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER
    Almodovar, M.
    Ramos, H.
    Mota, P.
    Martins, V.
    Pereira, P.
    LUNG CANCER, 2011, 71 : S42 - S43
  • [38] Survival outcomes of patients with non-small cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, So-Hee
    Kim, Ju Hwan
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 409 - 410
  • [39] Outcomes of lobectomy following chemoradiation for locally advanced non-small cell lung cancer
    Farlow, Erin Corinne
    Kim, Anthony W.
    Liptay, Michael J.
    Warren, William H.
    Basu, Sanjib
    Bonomi, Philip
    Faber, L. Penfield
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S300 - S301
  • [40] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
12345